These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28257335)

  • 1. Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.
    Schuetz P; Birkhahn R; Sherwin R; Jones AE; Singer A; Kline JA; Runyon MS; Self WH; Courtney DM; Nowak RM; Gaieski DF; Ebmeyer S; Johannes S; Wiemer JC; Schwabe A; Shapiro NI
    Crit Care Med; 2017 May; 45(5):781-789. PubMed ID: 28257335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of lipopolysaccharide binding protein and procalcitonin in patients with severe sepsis and septic shock admitted to intensive care].
    García de Guadiana-Romualdo LM; Rebollo-Acebes S; Esteban-Torrella P; Jiménez-Sánchez R; Hernando-Holgado A; Ortín-Freire A; Viqueira-González M; Trujillo-Santos J; Jiménez Santos E; Pedregosa Díaz J; Albaladejo-Otón MD; Allegue-Gallego JM
    Med Intensiva; 2015 May; 39(4):207-12. PubMed ID: 24953001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
    Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
    JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock].
    Suberviola B; Castellanos-Ortega A; González-Castro A; García-Astudillo LA; Fernández-Miret B
    Med Intensiva; 2012 Apr; 36(3):177-84. PubMed ID: 22055776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin as a prognostic marker for sepsis: a prospective observational study.
    Jain S; Sinha S; Sharma SK; Samantaray JC; Aggrawal P; Vikram NK; Biswas A; Sood S; Goel M; Das M; Vishnubhatla S; Khan N
    BMC Res Notes; 2014 Jul; 7():458. PubMed ID: 25034373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock.
    Park DW; Kwak DS; Park YY; Chang Y; Huh JW; Lim CM; Koh Y; Song DK; Hong SB
    J Crit Care; 2014 Oct; 29(5):882.e5-11. PubMed ID: 24961965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
    Yin Q; Liu B; Chen Y; Zhao Y; Li C
    Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.
    Prkno A; Wacker C; Brunkhorst FM; Schlattmann P
    Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.
    Liu B; Chen YX; Yin Q; Zhao YZ; Li CS
    Crit Care; 2013 Oct; 17(5):R244. PubMed ID: 24138799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin is Higher in Sepsis Than in Noninfectious SIRS and Predicts 30-Day Mortality of SIRS Patients in the Intensive Care.
    Kemperman H; Schrijver IT; Roest M; Kesecioglu J; van Solinge WW; de Lange DW
    J Appl Lab Med; 2019 Jan; 3(4):559-568. PubMed ID: 31639725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of procalcitonin in patients with septic shock.
    Clec'h C; Ferriere F; Karoubi P; Fosse JP; Cupa M; Hoang P; Cohen Y
    Crit Care Med; 2004 May; 32(5):1166-9. PubMed ID: 15190968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The predictor value of peripheral blood procalcitonin levels in the evaluation of prognosis of patients with septic shock].
    Chen W; Li LJ; Gu XY; Wang SZ; Zhao L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Aug; 24(8):470-3. PubMed ID: 22871405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lactic acid, lactate clearance and procalcitonin in assessing the severity and predicting prognosis in sepsis].
    Zhao M; Duan M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):449-453. PubMed ID: 32527351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declining mortality due to severe sepsis and septic shock in Spanish intensive care units: A two-cohort study in 2005 and 2011.
    Sánchez B; Ferrer R; Suarez D; Romay E; Piacentini E; Gomà G; Martínez ML; Artigas A;
    Med Intensiva; 2017; 41(1):28-37. PubMed ID: 28029501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].
    Hao C; Hu Q; Zhu L; Xu H; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):281-285. PubMed ID: 33834968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock.
    Ríos-Toro JJ; Márquez-Coello M; García-Álvarez JM; Martín-Aspas A; Rivera-Fernández R; Sáez de Benito A; Girón-González JA
    PLoS One; 2017; 12(4):e0175254. PubMed ID: 28380034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
    Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
    Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock.
    Kim CH; Park JT; Kim EJ; Han JH; Han JS; Choi JY; Han SH; Yoo TH; Kim YS; Kang SW; Oh HJ
    Crit Care; 2013 Dec; 17(6):R282. PubMed ID: 24321201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
    Angstwurm MW; Engelmann L; Zimmermann T; Lehmann C; Spes CH; Abel P; Strauss R; Meier-Hellmann A; Insel R; Radke J; Schüttler J; Gärtner R
    Crit Care Med; 2007 Jan; 35(1):118-26. PubMed ID: 17095947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.